288 related articles for article (PubMed ID: 34867971)
1. Clinical Value of
Liang J; Cao H; Wu B; Liu Y; He Y; Xu B; Sun Y; Ye B; Lin J
Front Immunol; 2021; 12():745211. PubMed ID: 34867971
[TBL] [Abstract][Full Text] [Related]
2. The lungs were on fire: a pilot study of
Liang J; Cao H; Liu Y; Ye B; Sun Y; Ke Y; He Y; Xu B; Lin J
Arthritis Res Ther; 2021 Jul; 23(1):198. PubMed ID: 34301306
[TBL] [Abstract][Full Text] [Related]
3. Elevated spleen FDG uptake predicts unfavorable outcome in adult idiopathic-inflammatory-myopathy patients: a crisis beyond muscles.
Liu Y; Wang G; Wang H; Zhao X; Chen D; Su X; Yan J; Liang J; Lin J; Zhao K
Clin Rheumatol; 2022 Jul; 41(7):2103-2112. PubMed ID: 35305186
[TBL] [Abstract][Full Text] [Related]
4. Prognosis predicting value of semiquantitative parameters of visceral adipose tissue and subcutaneous adipose tissue of
Liu J; Yang X; Yang J
Ann Nucl Med; 2021 Mar; 35(3):386-396. PubMed ID: 33469854
[TBL] [Abstract][Full Text] [Related]
5. Multiple values of
Li Y; Zhou Y; Wang Q
Clin Rheumatol; 2017 Oct; 36(10):2297-2305. PubMed ID: 28831580
[TBL] [Abstract][Full Text] [Related]
6. Radiological Characteristics of Patients With Anti-MDA5-Antibody-Positive Dermatomyositis in
Cao H; Liang J; Xu D; Liu Y; Yao Y; Sun Y; He Y; Lin J
Front Med (Lausanne); 2021; 8():779272. PubMed ID: 34881270
[No Abstract] [Full Text] [Related]
7.
Wei A; Lu X; Ma H; Lian H; Yang X; Zhang L; Wang D; Chen S; Zhang Q; Li Z; Zhang R; Yang J; Wang T
Contrast Media Mol Imaging; 2022; 2022():4849081. PubMed ID: 35510179
[TBL] [Abstract][Full Text] [Related]
8. 18F-FDG PET/CT and HRCT: a combined tool for risk stratification in idiopathic inflammatory myopathy-associated interstitial lung disease.
Zhang Y; Chen Z; Long Y; Zhang B; He Q; Tang K; Zhang X
Clin Rheumatol; 2022 Oct; 41(10):3095-3105. PubMed ID: 35759126
[TBL] [Abstract][Full Text] [Related]
9. The role of
Zheng Y; Hu G; Liu Y; Ma Y; Dang Y; Li F; Xing H; Wang T; Huo L
Clin Radiol; 2016 Dec; 71(12):1248-1254. PubMed ID: 27387105
[TBL] [Abstract][Full Text] [Related]
10. [Clinical features and risk factors for secondary hemophagocytic lymphohistiocytosis in elderly patients with severe SARS-CoV-2 infection: a multicenter retrospective cohort study].
Deng Y; Lu S; Zhang G; Sun W; Chu Y; Meng M; Cui Y; Li P
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2023 Aug; 35(8):793-799. PubMed ID: 37593855
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for secondary hemophagocytic lymphohistiocytosis in severe coronavirus disease 2019 adult patients.
Meng M; Chen L; Zhang S; Dong X; Li W; Li R; Deng Y; Wang T; Xu Y; Liu J; Huang Y; Chen Y; Huang S; Wen Z; Zhang L; Du H; Liu Y; Annane D; Qu J; Chen D
BMC Infect Dis; 2021 Apr; 21(1):398. PubMed ID: 33926377
[TBL] [Abstract][Full Text] [Related]
12. The significance of 18F-FDG PET/CT in secondary hemophagocytic lymphohistiocytosis.
Zhang LJ; Xu J; Liu P; Ding CY; Li JY; Qiu HX; Zhang SJ
J Hematol Oncol; 2012 Jul; 5():40. PubMed ID: 22824539
[TBL] [Abstract][Full Text] [Related]
13. The prognostic role of C-reactive protein to albumin ratio and anti-MDA5 antibody-positive in idiopathic inflammatory myopathy: a retrospective study.
Zhou P; Shen Q; Zhou S; Ouyang X; Guo T; Song M; Guo W; Zhang Y; Peng H
Sci Rep; 2023 Mar; 13(1):3863. PubMed ID: 36890164
[TBL] [Abstract][Full Text] [Related]
14. Inflammation Unrestrained by SIRPα Induces Secondary Hemophagocytic Lymphohistiocytosis Independent of IFN-γ.
Kidder K; Bian Z; Shi L; Liu Y
J Immunol; 2020 Nov; 205(10):2821-2833. PubMed ID: 33028619
[TBL] [Abstract][Full Text] [Related]
15. The significance of pre-therapeutic F-18-FDG PET-CT in lymphoma-associated hemophagocytic lymphohistiocytosis when pathological evidence is unavailable.
Wang J; Wang D; Zhang Q; Duan L; Tian T; Zhang X; Li J; Qiu H
J Cancer Res Clin Oncol; 2016 Apr; 142(4):859-71. PubMed ID: 26666755
[TBL] [Abstract][Full Text] [Related]
16. Utility of positron emission tomography as a new tool for muscle involvement in patients with idiopathic inflammatory myositis: a controlled study.
Bektaş M; Işık EG; Oğuz E; Kemik F; Abbasgholizadeh A; İnce B; Özkan ZG; Yalçınkaya Y; Artım-Esen B; Gül A; İnanç M
Clin Exp Rheumatol; 2024 Feb; 42(2):358-366. PubMed ID: 38293968
[TBL] [Abstract][Full Text] [Related]
17. Long-term risks of malignancy in myositis-specific antibody-positive idiopathic inflammatory myopathy.
Izuka S; Komai T; Shoda H; Fujio K
Rheumatol Int; 2023 Feb; 43(2):335-343. PubMed ID: 36175662
[TBL] [Abstract][Full Text] [Related]
18. The signature and predictive value of immune parameters in patients with secondary hemophagocytic lymphohistiocytosis.
Bai H; Wang Y; Shen L; Luo Y; Tang G; Wang F; Sun Z; Hou H
Immunobiology; 2023 Nov; 228(6):152759. PubMed ID: 37939638
[TBL] [Abstract][Full Text] [Related]
19. Prognosis of adult idiopathic inflammatory myopathy-associated interstitial lung disease: a retrospective study of 679 adult cases.
Li S; Sun Y; Shao C; Huang H; Wang Q; Xu K; Zhang X; Liu P; Zeng X; Xu Z
Rheumatology (Oxford); 2021 Mar; 60(3):1195-1204. PubMed ID: 32894294
[TBL] [Abstract][Full Text] [Related]
20. Analysis of risk factors of interstitial lung disease and mortality rates in Chinese patients with idiopathic inflammatory myopathy.
Bai Z; Shen G; Dong L
Int J Rheum Dis; 2021 Jun; 24(6):815-827. PubMed ID: 34028988
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
